| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/08/2010 | US20100173886 Bicyclic aryl and heteroaryl compounds for the treatment of metabolic disorders |
| 07/08/2010 | US20100173885 Organometeallic compounds |
| 07/08/2010 | US20100173884 Use of a phytosterol containing composition for the treatment of luts |
| 07/08/2010 | US20100173883 7-hydroxyepiandrosterone having neuroprotective activity |
| 07/08/2010 | US20100173882 Steroidal Compositions |
| 07/08/2010 | US20100173881 Compositions for the treatment of inflammatory disorders |
| 07/08/2010 | US20100173880 Alkaloid aminoester derivatives and medicinal composition thereof |
| 07/08/2010 | US20100173879 Use of a compound antagonist to the nk2 receptors of neurokinin a for the preparation of drugs useful for preventing and treating of sexual dysfunction |
| 07/08/2010 | US20100173878 Organic compounds |
| 07/08/2010 | US20100173877 Multi-phase contraceptive preparation based on a natural estrogen |
| 07/08/2010 | US20100173876 Oil-based nsaid compositions and methods for making and using same |
| 07/08/2010 | US20100173875 Formulation of aspirin that is stable and showing minimal hydrolysis for parenteral adminstration for the treatment of cardiovascular and other disease states |
| 07/08/2010 | US20100173874 Delivery of modulators of glutamate-mediated neurotransmission to the inner ear |
| 07/08/2010 | US20100173873 Treatment of metastasized tumors |
| 07/08/2010 | US20100173872 Method and Composition for Treating Alzheimer's Disease and Dementias of Vascular Origin |
| 07/08/2010 | US20100173871 Phosphorylated dendrimers as antiinflammatory drugs |
| 07/08/2010 | US20100173870 Phosphonate Compounds |
| 07/08/2010 | US20100173869 Treatment of surfactants |
| 07/08/2010 | US20100173868 Composition and method for healing tissues |
| 07/08/2010 | US20100173867 Injectable cross-linked polymeric preparations and uses thereof |
| 07/08/2010 | US20100173866 Apparatus and method for ocular treatment |
| 07/08/2010 | US20100173865 Anti-Cancer Agent-Hyaluronic Acid Conjugate Compositions and Methods |
| 07/08/2010 | US20100173864 Compositions including triciribine and one or more platinum compounds and methods of use thereof |
| 07/08/2010 | US20100173863 2-Fluoronucleosides |
| 07/08/2010 | US20100173862 Injectable, injection solution, and injection kit preparation |
| 07/08/2010 | US20100173861 Combinational paradigm combating hiv, hiv/hsv, or hiv/hpv infections in humans using small molecular weight compounds from plants |
| 07/08/2010 | US20100173860 Purifications of Pomegranate Ellagitannins and Their Uses Thereof |
| 07/08/2010 | US20100173859 Pharmaceutical formulation for the production of rapidly disintergrating tablets |
| 07/08/2010 | US20100173858 Compositions to treat bacterial and inflammatory affections in pet animals dosage form and method to treat pet animals |
| 07/08/2010 | US20100173857 Spinosyns For Wound Healing |
| 07/08/2010 | US20100173856 Methods of producing and using nutritional and pharmaceutical compositions that include one or more active substances |
| 07/08/2010 | US20100173855 Dermatological Formulations |
| 07/08/2010 | US20100173854 Microfluidized Oil-in-water Emulsions and Vaccine Compositions |
| 07/08/2010 | US20100173852 USE OF AGENTS THAT DOWN-REGULATE EXPRESSION OF TANIS AND/OR P21 Waf1/Cip1/Sd1 GENES, AND USE OF AGENTS THAT INHIBIT, DEGRADE, SEQUESTER OR PREVENT THE NEUROTOXICITY OF GENE PRODUCT PROTEINS OF TANIS AND P21 Waf1/Cip1/Sd1 GENES |
| 07/08/2010 | US20100173842 Vaccine for staphylococcal infections |
| 07/08/2010 | US20100173826 Smooth Muscle Relaxation |
| 07/08/2010 | US20100173825 Heteroaryl benzamide derivatives |
| 07/08/2010 | US20100173824 Azepinoindole Derivatives As Pharmaceutical Agents |
| 07/08/2010 | US20100173823 Alpha2c adrenoreceptor agonists |
| 07/08/2010 | US20100173779 Composition and method to stimulate growth and defense against pathogens in plants |
| 07/08/2010 | US20100173413 Pyridine compounds |
| 07/08/2010 | US20100173327 Nonhuman model animal lacking the ability to control lymphocyte migration |
| 07/08/2010 | US20100173319 Compositions and methods for cancer diagnosis and therapy |
| 07/08/2010 | US20100173317 Method for diagnosing non-small cell lung cancer |
| 07/08/2010 | US20100173028 Process for preparing vitis vinifera pip extract and pharmaceutical composition for preventing or treating rheumatoid arthritis comprising the same |
| 07/08/2010 | US20100173027 O/w emulsion for hand care |
| 07/08/2010 | US20100173024 Methods and compositions for altering health, wellbeing, and lifespan |
| 07/08/2010 | US20100173021 Topical Product formulations containing strontium for reducing skin irritation |
| 07/08/2010 | US20100173019 Method of stabilizing human eye tissue by reaction with nitrite and related agents such as nitro compounds |
| 07/08/2010 | US20100173014 Methods of making and using nano scale particles |
| 07/08/2010 | US20100173013 Treatment of neoplastic disorders using combination therapies |
| 07/08/2010 | US20100173010 Polymetaphosphate based formulations for therapy of microcrystalline arthropathies |
| 07/08/2010 | US20100173005 Microparticle formulations for sustained-release of bioactive compounds |
| 07/08/2010 | US20100173002 Microcapsules with improved shells |
| 07/08/2010 | US20100173001 Metal Ion-Treated Biocompatible Polymers Useful for Nanoparticles |
| 07/08/2010 | US20100172998 Process for preparing microparticles through phase inversion phenomena |
| 07/08/2010 | US20100172995 Process For Preparing A Solid Pharmaceutical Composition |
| 07/08/2010 | US20100172993 Particles for delivery of active ingredients, process of making and compositions thereof |
| 07/08/2010 | US20100172991 Extended Release Formulation and Methods of Treating Adrenergic Dysregulation |
| 07/08/2010 | US20100172990 Biocompatible microgels and applications thereof |
| 07/08/2010 | US20100172989 Abuse resistant melt extruded formulation having reduced alcohol interaction |
| 07/08/2010 | US20100172988 Sustained release preparation and method for production thereof |
| 07/08/2010 | US20100172987 Three Layer Tablet Containing Cetirizine, Pseudoephedrine, and Naproxen |
| 07/08/2010 | US20100172986 Controlled release composition and preparation thereof |
| 07/08/2010 | US20100172985 Tablet Containing Cetirizine, Pseudoephedrine, and Naproxen Containing a Barrier Layer |
| 07/08/2010 | US20100172984 tablet dosage form comprising cetirizine and pseudoephedrine |
| 07/08/2010 | US20100172983 Pharmaceutical Compositions for the Coordinated Delivery of Naproxen and Esomeprazole |
| 07/08/2010 | US20100172982 Sustained release formulations of divalproex sodium |
| 07/08/2010 | US20100172981 Ibuprofen-Effervescent Preparation Having a High Dissolution Rate and Method for the Production thereof |
| 07/08/2010 | US20100172980 Tablet Containing Coated Particles of Cetirizine, Pseudoephedrine, and/or Naproxen |
| 07/08/2010 | US20100172979 Controlled-release formulations |
| 07/08/2010 | US20100172977 Abscisic acid against cancer |
| 07/08/2010 | US20100172976 Methods and compositions for inhibiting the function of polynucleotide sequences |
| 07/08/2010 | US20100172975 Treatment of hyperproliferative disorders with diarylhydantoin compounds |
| 07/08/2010 | US20100172974 Melt-extruded orally administrable opioid formulations |
| 07/08/2010 | US20100172973 Pharmaceutical Composition |
| 07/08/2010 | US20100172972 Enteric coated pharmaceutical compositions |
| 07/08/2010 | US20100172971 Compositions for Inhibiting NADPH Oxidase Activity |
| 07/08/2010 | US20100172970 Dosage forms made by melt extrusion with water soluble polymer to improve bioavailability; once daily oral dosage form; antivirals such as 4-[[4-amino-5-chloro-6-[(2,4,6-trimethylphenyl)amino]-2-pyrimidinyl]amino]benzonitrile for treating non-nucleoside reverse transcriptase inhibitor resistant HIV |
| 07/08/2010 | US20100172969 Hot-melt micropellets |
| 07/08/2010 | US20100172966 Methods and compositions for cellular reprogramming |
| 07/08/2010 | US20100172965 Antiviral oligonucleotides targeting viral families |
| 07/08/2010 | US20100172964 Vesicle useful for external preparation for skin, and external preparation for skin comprising the vesicle |
| 07/08/2010 | US20100172963 Medicinal agent for treating patients suffering from diseases caused by the monoaminooxidase excessive activity and a method for treating patients suffering |
| 07/08/2010 | US20100172962 Therapeutic targeting of interleukins using sirna in neutral liposomes |
| 07/08/2010 | US20100172960 Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses |
| 07/08/2010 | US20100172959 Reservoir system with closed membrane |
| 07/08/2010 | US20100172958 Wound dressing devices and methods |
| 07/08/2010 | US20100172957 Eflucimibe medicaments for preventing/treating a disease due to sebaceous gland dysfunction in humans or animals |
| 07/08/2010 | US20100172950 Pharmaceutical compositions comprising dextran with a molecular weight of 1.0-100 kda and processes for their preparation |
| 07/08/2010 | US20100172946 Matrix-type transdermal drug delivery system and preparation method thereof |
| 07/08/2010 | US20100172937 Enveloped virus neutralizing compounds |
| 07/08/2010 | US20100172933 Recombinant vectors based on the modified vaccinia ankara (mva) virus as vaccines against lieshmaniasis |
| 07/08/2010 | US20100172930 Transfection complexes |
| 07/08/2010 | US20100172922 Expression and Purification of HIP/PAP and Uses Therefor |
| 07/08/2010 | US20100172916 Substituted hydroxyphenylamine compounds |
| 07/08/2010 | US20100172905 Antagonists of hmg1 for treating inflammatory conditions |
| 07/08/2010 | US20100172903 Combination of an Anti-Ep-CAM Antibody with a Chemotherapeutic Agent |
| 07/08/2010 | US20100172898 Microstructure synthesis by flow lithography and polymerization |
| 07/08/2010 | US20100172896 Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases |